BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9446757)

  • 1. Hematologically important mutations: band 3 and protein 4.2 variants in hereditary spherocytosis.
    Gallagher PG; Forget BG
    Blood Cells Mol Dis; 1997 Dec; 23(3):417-21. PubMed ID: 9446757
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population.
    Yawata Y; Kanzaki A; Yawata A; Doerfler W; Ozcan R; Eber SW
    Int J Hematol; 2000 Feb; 71(2):118-35. PubMed ID: 10745622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of hereditary spherocytosis].
    Yawata Y
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1825-33. PubMed ID: 10581770
    [No Abstract]   [Full Text] [Related]  

  • 4. Heavy transfusions and presence of an anti-protein 4.2 antibody in 4. 2(-) hereditary spherocytosis (949delG).
    Beauchamp-Nicoud A; Morle L; Lutz HU; Stammler P; Agulles O; Petermann-Khder R; Iolascon A; Perrotta S; Cynober T; Tchernia G; Delaunay J; Baudin-Creuza V
    Haematologica; 2000 Jan; 85(1):19-24. PubMed ID: 10629586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary spherocytosis due to band 3 deficiency: 15 novel mutations in SLC4A1.
    Van Zwieten R; François JJ; Van Leeuwen K; Van Wesel AC; Van Bruggen R; Van Solinge WW; Roos D; Verhoeven AJ; Van Wijk R
    Am J Hematol; 2013 Feb; 88(2):159-60. PubMed ID: 23255290
    [No Abstract]   [Full Text] [Related]  

  • 6. Band 3Tambaú: a de novo mutation in the AE1 gene associated with hereditary spherocytosis. Implications for anion exchange and insertion into the red blood cell membrane.
    Lima PR; Baratti MO; Chiattone ML; Costa FF; Saad ST
    Eur J Haematol; 2005 May; 74(5):396-401. PubMed ID: 15813913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanism of hereditary spherocytosis].
    Bogusławska DM; Heger E; Sikorski AF
    Pol Merkur Lekarski; 2006 Jan; 20(115):112-6. PubMed ID: 16617750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4.2 Nippon mutation in a non-Japanese patient with hereditary spherocytosis.
    Perrotta S; Iolascon A; Polito R; d'Urzo G; Conte ML; Miraglia del Giudice E
    Haematologica; 1999 Jul; 84(7):660-2. PubMed ID: 10406914
    [No Abstract]   [Full Text] [Related]  

  • 9. A de novo band 3 mutation in hereditary spherocytosis.
    Bogardus HH; Maksimova YD; Forget BG; Gallagher PG
    Pediatr Blood Cancer; 2012 Jun; 58(6):1004. PubMed ID: 22170767
    [No Abstract]   [Full Text] [Related]  

  • 10. Co-existence of hereditary spherocytosis and a new red cell pyruvate kinase variant: PK mallorca.
    Zarza R; Moscardó M; Alvarez R; García J; Morey M; Pujades A; Vives-Corrons JL
    Haematologica; 2000 Mar; 85(3):227-32. PubMed ID: 10702808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology of inherited erythrocyte membrane disorders: hereditary spherocytosis and elliptocytosis.
    Iolascon A; Miraglia del Giudice E; Camaschella C
    Haematologica; 1992; 77(1):60-72. PubMed ID: 1356891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and stability of hereditary spherocytosis mutants of the cytosolic domain of the erythrocyte anion exchanger 1 protein.
    Bustos SP; Reithmeier RA
    Biochemistry; 2006 Jan; 45(3):1026-34. PubMed ID: 16411779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the clinical spectrum and genetics of red blood cell membrane disorders.
    Gallagher PG
    Curr Hematol Rep; 2004 Mar; 3(2):85-91. PubMed ID: 14965483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical expression and laboratory detection of red blood cell membrane protein mutations.
    Palek J; Jarolim P
    Semin Hematol; 1993 Oct; 30(4):249-83. PubMed ID: 8266114
    [No Abstract]   [Full Text] [Related]  

  • 15. [Red cell membrane disorders: historical perspectives from dawn to enlightenment (II)].
    Yawata Y
    Rinsho Ketsueki; 1999 Dec; 40(12):1223-35. PubMed ID: 10658475
    [No Abstract]   [Full Text] [Related]  

  • 16. Hematologically important mutations: ankyrin variants in hereditary spherocytosis.
    Gallagher PG
    Blood Cells Mol Dis; 2005; 35(3):345-7. PubMed ID: 16223590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell membrane polypeptides under normal conditions and in genetic disorders.
    Delaunay J
    Transfus Clin Biol; 1995; 2(4):207-16. PubMed ID: 8542017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary spherocytosis: one year study of erythrocyte membrane proteins].
    Tshilolo L; Kagambega F; Sztern B; Vertongen F; Gulbis B
    Rev Med Brux; 1998 Oct; 19(5 Pt 1):417-23. PubMed ID: 9844481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein 4.2 interaction with hereditary spherocytosis mutants of the cytoplasmic domain of human anion exchanger 1.
    Bustos SP; Reithmeier RA
    Biochem J; 2011 Jan; 433(2):313-22. PubMed ID: 21039340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nonsense mutation in the erythrocyte band 3 gene associated with decreased mRNA accumulation in a kindred with dominant hereditary spherocytosis.
    Jenkins PB; Abou-Alfa GK; Dhermy D; Bursaux E; Féo C; Scarpa AL; Lux SE; Garbarz M; Forget BG; Gallagher PG
    J Clin Invest; 1996 Jan; 97(2):373-80. PubMed ID: 8567957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.